232 related articles for article (PubMed ID: 22454589)
1. Recent Findings Concerning PAMAM Dendrimer Conjugates with Cyclodextrins as Carriers of DNA and RNA.
Arima H; Motoyama K
Sensors (Basel); 2009; 9(8):6346-61. PubMed ID: 22454589
[TBL] [Abstract][Full Text] [Related]
2. Sugar-appended polyamidoamine dendrimer conjugates with cyclodextrins as cell-specific non-viral vectors.
Arima H; Motoyama K; Higashi T
Adv Drug Deliv Rev; 2013 Aug; 65(9):1204-14. PubMed ID: 23602906
[TBL] [Abstract][Full Text] [Related]
3. Potential use of folate-polyethylene glycol (PEG)-appended dendrimer (G3) conjugate with α-cyclodextrin as DNA carriers to tumor cells.
Arima H; Arizono M; Higashi T; Yoshimatsu A; Ikeda H; Motoyama K; Hattori K; Takeuchi T; Hirayama F; Uekama K
Cancer Gene Ther; 2012 May; 19(5):358-66. PubMed ID: 22402627
[TBL] [Abstract][Full Text] [Related]
4. Folate-PEG-appended dendrimer conjugate with α-cyclodextrin as a novel cancer cell-selective siRNA delivery carrier.
Arima H; Yoshimatsu A; Ikeda H; Ohyama A; Motoyama K; Higashi T; Tsuchiya A; Niidome T; Katayama Y; Hattori K; Takeuchi T
Mol Pharm; 2012 Sep; 9(9):2591-604. PubMed ID: 22873579
[TBL] [Abstract][Full Text] [Related]
5. Cyclodextrin/Dendrimer conjugates as DNA and oligonucleotide carriers.
Arima H; Motoyama K; Higashi T
Curr Top Med Chem; 2014; 14(4):465-77. PubMed ID: 24354672
[TBL] [Abstract][Full Text] [Related]
6. In Vitro and In Vivo Tumor-Targeting siRNA Delivery Using Folate-PEG-appended Dendrimer (G4)/α-Cyclodextrin Conjugates.
Ohyama A; Higashi T; Motoyama K; Arima H
Bioconjug Chem; 2016 Mar; 27(3):521-32. PubMed ID: 26715308
[TBL] [Abstract][Full Text] [Related]
7. Potential therapeutic application of dendrimer/cyclodextrin conjugates with targeting ligands as advanced carriers for gene and oligonucleotide drugs.
Arima H; Motoyama K; Higashi T
Ther Deliv; 2017 Apr; 8(4):215-232. PubMed ID: 28222660
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo gene delivery mediated by Lactosylated dendrimer/alpha-cyclodextrin conjugates (G2) into hepatocytes.
Arima H; Yamashita S; Mori Y; Hayashi Y; Motoyama K; Hattori K; Takeuchi T; Jono H; Ando Y; Hirayama F; Uekama K
J Control Release; 2010 Aug; 146(1):106-17. PubMed ID: 20678990
[TBL] [Abstract][Full Text] [Related]
9. Preparation and evaluation of polyamidoamine dendrimer conjugate with glucuronylglucosyl-β-cyclodextrin (G3) as a novel carrier for siRNA.
Abdelwahab AF; Ohyama A; Higashi T; Motoyama K; Khaled KA; Sarhan HA; Hussein AK; Arima H
J Drug Target; 2014 Dec; 22(10):927-34. PubMed ID: 25148608
[TBL] [Abstract][Full Text] [Related]
10. Effects of structure of polyamidoamine dendrimer on gene transfer efficiency of the dendrimer conjugate with alpha-cyclodextrin.
Kihara F; Arima H; Tsutsumi T; Hirayama F; Uekama K
Bioconjug Chem; 2002; 13(6):1211-9. PubMed ID: 12440855
[TBL] [Abstract][Full Text] [Related]
11. Potential use of lactosylated dendrimer (G3)/α-cyclodextrin conjugates as hepatocyte-specific siRNA carriers for the treatment of familial amyloidotic polyneuropathy.
Hayashi Y; Mori Y; Yamashita S; Motoyama K; Higashi T; Jono H; Ando Y; Arima H
Mol Pharm; 2012 Jun; 9(6):1645-53. PubMed ID: 22510029
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo gene transfer by an optimized alpha-cyclodextrin conjugate with polyamidoamine dendrimer.
Kihara F; Arima H; Tsutsumi T; Hirayama F; Uekama K
Bioconjug Chem; 2003; 14(2):342-50. PubMed ID: 12643744
[TBL] [Abstract][Full Text] [Related]
13. Design and evaluation of thioalkylated mannose-modified dendrimer (G3)/α-cyclodextrin conjugates as antigen-presenting cell-selective siRNA carriers.
Motoyama K; Mitsuyasu R; Akao C; Tanaka T; Ohyama A; Sato N; Higashi T; Arima H
AAPS J; 2014 Nov; 16(6):1298-308. PubMed ID: 25236864
[TBL] [Abstract][Full Text] [Related]
14. In Vitro and In Vivo Co-delivery of siRNA and Doxorubicin by Folate-PEG-Appended Dendrimer/Glucuronylglucosyl-β-Cyclodextrin Conjugate.
Mohammed AFA; Higashi T; Motoyama K; Ohyama A; Onodera R; Khaled KA; Sarhan HA; Hussein AK; Arima H
AAPS J; 2019 Apr; 21(4):54. PubMed ID: 30993472
[TBL] [Abstract][Full Text] [Related]
15. [Polyfection as nonviral gene transfer method -design of novel nonviral vector using alpha-cyclodextrin].
Arima H
Yakugaku Zasshi; 2004 Jul; 124(7):451-64. PubMed ID: 15235229
[TBL] [Abstract][Full Text] [Related]
16. Twenty Years of Research on Cyclodextrin Conjugates with PAMAM Dendrimers.
Arima H
Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34064866
[TBL] [Abstract][Full Text] [Related]
17. Potential Use of Thioalkylated Mannose-Modified Dendrimer (G3)/α-Cyclodextrin Conjugate as an NF-κB siRNA Carrier for the Treatment of Fulminant Hepatitis.
Motoyama K; Mitsuyasu R; Akao C; Abu Hashim II; Sato N; Tanaka T; Higashi T; Arima H
Mol Pharm; 2015 Sep; 12(9):3129-36. PubMed ID: 26270769
[TBL] [Abstract][Full Text] [Related]
18. Design and evaluation of polyamidoamine dendrimer conjugate with PEG, α-cyclodextrin and lactose as a novel hepatocyte-selective gene carrier in vitro and in vivo.
Hayashi Y; Higashi T; Motoyama K; Mori Y; Jono H; Ando Y; Arima H
J Drug Target; 2013 May; 21(5):487-96. PubMed ID: 23570609
[TBL] [Abstract][Full Text] [Related]
19. Enhancing effects of galactosylated dendrimer/alpha-cyclodextrin conjugates on gene transfer efficiency.
Wada K; Arima H; Tsutsumi T; Hirayama F; Uekama K
Biol Pharm Bull; 2005 Mar; 28(3):500-5. PubMed ID: 15744077
[TBL] [Abstract][Full Text] [Related]
20. Potential use of glucuronylglucosyl-β-cyclodextrin/dendrimer conjugate (G2) as a siRNA carrier for the treatment of familial amyloidotic polyneuropathy.
Anno T; Higashi T; Hayashi Y; Motoyama K; Jono H; Ando Y; Arima H
J Drug Target; 2014 Dec; 22(10):883-90. PubMed ID: 25051178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
